Explantation of Patent Foramen Ovale Closure Devices
Authors:
- Jonathan M. TobisJTJonathan M. Tobis
- 1 May 2011
- journal article
- case report
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 4 (5) , 579-585
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Metal Allergy—A Review on Exposures, Penetration, Genetics, Prevalence, and Clinical ImplicationsChemical Research in Toxicology, 2009
- Systemic Contact DermatitisDermatologic Clinics, 2009
- The significance of patent foramen ovaleInternational Journal of Cardiology, 2009
- Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre studyJournal of Cardiovascular Medicine, 2009
- Cryptogenic stroke and patent foramen ovaleCurrent Opinion in Cardiology, 2008
- Patent foramen ovale closure with the Intrasept occluder: Complete 6–56 months follow‐up of 247 patients after presumed paradoxical embolismCatheterization and Cardiovascular Interventions, 2008
- Transcatheter Closure versus Medical Therapy of Patent Foramen Ovale and Presumed Paradoxical ThromboemboliAnnals of Internal Medicine, 2003
- Experimental systemic contact dermatitis from nickel: a dose–response studyContact Dermatitis, 2003
- Corrosive behaviour of Amplatzer® devices in experimental and biological environmentsCardiology in the Young, 2002
- Incidence and Size of Patent Foramen Ovale During the First 10 Decades of Life: An Autopsy Study of 965 Normal HeartsMayo Clinic Proceedings, 1984